Abstract
Deep-sea water (DSW) and chitosan oligosaccharides (COS) have recently drawn much attention because of their potential medical and pharmaceutical applications. Balanced DSW (BDSW) was prepared by mixing DSW mineral extracts and desalinated water. This study investigated the effects of BDSW, COS, and BDSW containing COS on glucose uptake and their mode of action in mature C2C12 myotubes. BDSW and COS increased glucose uptake in a dose-dependent manner. BDSW containing COS synergistically increased glucose uptake; this was dependent on the activation of insulin receptor substrate 1 and protein kinase C in insulin-dependent signaling pathways as well as liver kinase B1, AMP-activated protein kinase, and mammalian target of rapamycin in insulin-independent signaling pathways. Quantitative real-time polymerase chain reaction revealed that the expressions of the following genes related to glucose uptake were elevated: glucose transporter 4 (GLUT4), insulin-responsive aminopeptidase, and vesicle-associated membrane protein 2 for abundant proteins of GLUT4 storage vesicles (GSVs); syntaxin 4 and soluble N-ethylmaleimide-sensitive factor attachment protein 23 for trafficking between the plasma membrane and GSVs; and syntaxin 6 and syntaxin 16 for trafficking between GSVs and the trans-Golgi network. Taken together, these results suggest BDSW containing COS has a greater stimulatory effect on glucose uptake than BDSW or COS alone. Moreover, this effect is mediated by the stimulation of diverse signaling pathways via the activation of main signaling molecules related to GSV trafficking.
Similar content being viewed by others
Abbreviations
- DSW:
-
Deep-sea water
- BDSW:
-
Balanced deep-sea water
- COS:
-
Chitosan oligosaccharides
- GSVs:
-
GLUT 4 storage vesicles
- IRS-1:
-
Insulin receptor substrate 1
- PI3-K:
-
Phosphatidylinositol 3-kinase
- PKC:
-
Protein kinase C
- LKB1:
-
Liver kinase B1
- AMPK:
-
AMP-activated protein kinase
- mTOR:
-
Mammalian target of rapamycin
- Sirt1:
-
Sirtuin 1
- GLUT4:
-
Glucose transporter 4
- IRAP:
-
Insulin-responsive aminopeptidase
- VAMP2:
-
Vesicle-associated membrane protein 2
- SNAP23:
-
Soluble N-ethylmaleimide-sensitive factor attachment protein 23
- SNARES:
-
Soluble N-ethylmaleimide-sensitive factor attachment protein receptor
- TGN:
-
trans-Golgi network
- NSF:
-
N-Ethylmaleimide-sensitive factor
- Syn 4:
-
Syntaxin 4
- Syn 6:
-
Syntaxin 6
- Syn 16:
-
Syntaxin 16
References
Bell DS (2006) The case for combination therapy as first-line treatment for the type 2 diabetic patient. Treat Endocrinol 5:131–137
Bell DS (2013) Combine and conquer: advantages and disadvantages of fixed-dose combination therapy. Diabetes Obes Metab 15:291–300
Bjornholm M, Kawano Y, Lehtihet M, Zierath JR (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524–527
Bogan JS (2012) Regulation of glucose transporter translocation in health and diabetes. Annu Rev Biochem 81:507–532
Choi CR, Kim EK, Kim YS, Je JY, An SH, Lee JD, Wang JH, Ki SS, Jeon BT, Moon SH, Park PJ (2012a) Chitooligosaccharides decreases plasma lipid levels in healthy men. Int J Food Sci Nutr 63:103–106
Choi EH, Yang HP, Chun HS (2012b) Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation. Nutr Res 32:218–228
Clark TA, Deniset JF, Heyliger CE, Pierce GN (2014) Alternative therapies for diabetes and its cardiac complications: role of vanadium. Heart Fail Rev 19:123–132
Copps KD, White MF (2012) Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55:2565–2582
Cornu M, Albert V, Hall MN (2013) mTOR in aging, metabolism, and cancer. Curr Opin Genet Dev 23:53–62
Destefano MA, Jacinto E (2013) Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2). Biochem Soc Trans 41:896–901
Fu ZY, Yang FL, Hsu HW, Lu YF (2012) Drinking deep seawater decreases serum total and low-density lipoprotein-cholesterol in hypercholesterolemic subjects. J Med Food 15:535–541
Ha BG, Shin EJ, Park JE, Shon YH (2013) Anti-diabetic effect of balanced deep-sea water and its mode of action in high-fat diet induced diabetic mice. Mar Drugs 11:4193–4212
Ha BG, Park JE, Shin EJ, Shon YH (2014a) Modulation of glucose metabolism by balanced deep-sea water ameliorates hyperglycemia and pancreatic function in streptozotocin-induced diabetic mice. PLoS One 9:e102095
Ha BG, Park JE, Shin EJ, Shon YH (2014b) Effects of balanced deep-sea water on adipocyte hypertrophy and liver steatosis in high-fat, diet-induced obese mice. Obesity (Silver Spring) 22:1669–1678
Hardie DG (2013) AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62:2164–2172
Hataguchi Y, Tai H, Nakajima H, Kimata H (2005) Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome. Eur J Clin Nutr 59:1093–1096
He S, Hao J, Peng W, Qiu P, Li C, Guan H (2014) Modulation of lipid metabolism by deep-sea water in cultured human liver (HepG2) cells. Mar Biotechnol (NY) 16(2):219–229
Huang S, Czech MP (2007) The GLUT4 glucose transporter. Cell Metab 5:237–252
Hung HY, Qian K, Morris-Natschke SL, Hsu CS, Lee KH (2012) Recent discovery of plant-derived anti-diabetic natural products. Nat Prod Rep 29:580–606
Hwang HS, Kim HA, Lee SH, Yun JW (2009a) Anti-obesity and antidiabetic effects of deep sea water on ob/ob mice. Mar Biotechnol (NY) 11:531–539
Hwang HS, Kim SH, Yoo YG, Chu YS, Shon YH, Nam KS, Yun JW (2009b) Inhibitory effect of deep-sea water on differentiation of 3T3-L1 adipocytes. Mar Biotechnol (NY) 11:161–168
Je JY, Kim SK (2012) Chitooligosaccharides as potential nutraceuticals: production and bioactivities. Adv Food Nutr Res 65:321–336
Jo SH, Ha KS, Moon KS, Kim JG, Oh CG, Kim YC, Apostolidis E, Kwon YI (2013) Molecular weight dependent glucose lowering effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model. Int J Mol Sci 14:14214–14224
Ju C, Yue W, Yang Z, Zhang Q, Yang X, Liu Z, Zhang F (2010) Antidiabetic effect and mechanism of chitooligosaccharides. Biol Pharm Bull 33:1511–1516
Jung DW, Ha HH, Zheng X, Chang YT, Williams DR (2011) Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects. Mol BioSyst 7:346–358
Katsuda S, Yasukawa T, Nakagawa K, Miyake M, Yamasaki M, Katahira K, Mohri M, Shimizu T, Hazama A (2008) Deep-sea water improves cardiovascular hemodynamics in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Biol Pharm Bull 31:38–44
Kim S, Chun SY, Lee DH, Lee KS, Nam KS (2013) Mineral-enriched deep-sea water inhibits the metastatic potential of human breast cancer cell lines. Int J Oncol 43:1691–1700
Leto D, Saltiel AR (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13:383–396
Liu HY, Liu MC, Wang MF, Chen WH, Tsai CY, Wu KH, Lin CT, Shieh YH, Zeng R, Deng WP (2013) Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice. Evid Based Complement Alternat Med 2013:161976
Miao X, Sun W, Fu Y, Miao L, Cai L (2013) Zinc homeostasis in the metabolic syndrome and diabetes. Front Med 7:31–52
Ni HX, Yu NJ, Yang XH (2010) The study of ginsenoside on PPARgamma expression of mononuclear macrophage in type 2 diabetes. Mol Biol Rep 37:2975–2979
Radhakrishnan G, Yamamoto M, Maeda H, Nakagawa A, Kataregopalrao R, Okada H, Nishimori H, Wariishi S, Toda E, Ogawa H, Sasaguri S (2009) Intake of dissolved organic matter from deep seawater inhibits atherosclerosis progression. Biochem Biophys Res Commun 387:25–30
Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S (2013) Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 1:CD009671
Rehder D (2012) The potentiality of vanadium in medicinal applications. Future Med Chem 4:1823–1837
Resnick LM (1992) Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med 93:11S–20S
Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017
Robertson DS (2006) Magnesium or calcium hypophosphite could be a treatment for obesity in humans. Med Hypotheses 66:439–440
Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123:2764–2772
Sajan MP, Bandyopadhyay G, Miura A, Standaert ML, Nimal S, Longnus SL, Van Obberghen E, Hainault I, Foufelle F, Kahn R, Braun U, Leitges M, Farese RV (2010) AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. Am J Physiol Endocrinol Metab 298:E179–E192
Squadrito F, Marini H, Bitto A, Altavilla D, Polito F, Adamo EB, D’anna R, Arcoraci V, Burnett BP, Minutoli L, Di Benedetto A, Di Vieste G, Cucinotta D, De Gregorio C, Russo S, Corrado F, Saitta A, Irace C, Corrao S, Licata G (2013) Genistein in the metabolic syndrome: results of a randomized clinical trial. J Clin Endocrinol Metab 98:3366–3374
Stockli J, Fazakerley DJ, James DE (2011) GLUT4 exocytosis. J Cell Sci 124:4147–4159
Tahrani AA, Piya MK, Kennedy A, Barnett AH (2010) Glycaemic control in type 2 diabetes: targets and new therapies. Pharmacol Ther 125:328–361
Tripathy D, Chavez AO (2010) Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep 10:184–191
Vouri SM, Shaw RF, Waterbury NV, Egge JA, Alexander B (2011) Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes. J Manag Care Pharm 17:304–312
Yamada E, Lee TW, Pessin JE, Bastie CC (2010) Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance. Future Med Chem 2:1785–1796
Yuan WP, Liu B, Liu CH, Wang XJ, Zhang MS, Meng XM, Xia XK (2009) Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats. World J Gastroenterol 15:1339–1345
Yun JW (2010) Possible anti-obesity therapeutics from nature—a review. Phytochemistry 71:1625–1641
Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN, Kong WJ, Jiang JD (2010a) Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59:285–292
Zhang J, Xia W, Liu P, Cheng Q, Tahirou T, Gu W, Li B (2010b) Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 8:1962–1987
Acknowledgments
This work was financially supported by the National R&D project of “Development of new application technology for deep seawater industry” supported by the Ministry of Oceans and Fisheries of the Republic of Korea and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Supplemental Table 1
(JPEG 43.9 kb)
Supplemental Table 2
(JPEG 94.8 kb)
Rights and permissions
About this article
Cite this article
Ha, B.G., Park, JE. & Shon, Y.H. Stimulatory Effect of Balanced Deep-Sea Water Containing Chitosan Oligosaccharides on Glucose Uptake in C2C12 Myotubes. Mar Biotechnol 18, 475–484 (2016). https://doi.org/10.1007/s10126-016-9709-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10126-016-9709-5